Congress seeking information about the Digitek recall
Congress has sent a letter to officials with the Food and Drug Administration asking the agency to provide it with more information about a series of drug recalls by Actavis Totowa, including one that involved Digitek. Actavis issued a Digitek recall in April 2008 after learning that some tablets of the heart medication were manufactured [...]
Nine federal Digitek lawsuits filed in N.J.
Nine federal Digitek lawsuits have been filed by patients in New Jersey against the drug’s manufacturer, Actavis Totowa. These lawsuits allege that Digitek was a dangerous and defective product because of improper manufacturing practices, putting patients at an increased risk of serious injury due to digoxin toxicity. At least one patient involved in the Digitek [...]
Actavis received two warnings because of “adulterated” drugs
In the wake of the Digitek recall, reports have emerged that Actavis Totowa, the manufacturer of the heart drug, received two warning letters from the Food and Drug Administration in 2006 and 2007. The letters charged the company with failing to properly report adverse events for drugs including Digitek and for failing to follow “Good [...]